G. I. Baikalov
Research Institute of Clinical and Experimental Lymphology, Branch of the Federal Research Center Institute of Cytology and Genetics; Novosibirsk State Medical University
Russian Federation

German I. Baikalov – Resident, Department of Pharmacology, Clinical Pharmacology and Evidence-Based Medicine, Novosibirsk State Medical University; Junior Researcher, Laboratory of Pharmacological Modeling and Screening of Bioactive Molecules, Research Institute of Clinical and Experimental Lymphology, Branch of the Federal Research Center Institute of Cytology and  Genetics.

Novosibirsk.

N. P. Leonov
Research Institute of Clinical and Experimental Lymphology, Branch of the Federal Research Center Institute of Cytology and Genetics
Russian Federation

Nikolai  P.  Leonov  –  Senior  Researcher,  Laboratory of Pharmaceutical Technology, Research Institute of Clinical  and  Experimental  Lymphology,  Branch  of the Federal Research Center Institute of Cytology and Genetics.

Novosibirsk.

P. G. Madonov
Research Institute of Clinical and Experimental Lymphology, Branch of the Federal Research Center Institute of Cytology and Genetics; Novosibirsk State Medical University
Russian Federation

Pavel G. Madonov – Dr. Sci. (Med.), Associate Professor, Head, Department of Pharmacology, Clinical Pharmacology and Evidence-Based Medicine, Novosibirsk State Medical University; Head, Department of Experimental Pharmacology, Research Institute of Clinical and Experimental Lymphology, Branch of the Federal Research Center Institute of Cytology and Genetics.

Novosibirsk.

K. I. Ershov
Research Institute of Clinical and Experimental Lymphology, Branch of the Federal Research Center Institute of Cytology and Genetics; Novosibirsk State Medical University
Russian Federation

Konstantin  I.  Ershov –  Cand.  Sci.  (Biol.),  Associate Professor, Department of Pharmacology, Clinical Pharmacology and Evidence-Based Medicine, Novosibirsk State Medical University; Senior Researcher, Laboratory of Pharmaceutical Technology, Research Institute of Clinical and Experimental Lymphology, Branch of the Federal Research Center Institute of Cytology and Genetics.

Novosibirsk.

R. A. Knyazev
Novosibirsk State Medical University
Russian Federation

Roman A. Knyazev – Cand. Sci. (Biol.), Associate Professor, Department of Pharmacology, Clinical Pharmacology and Evidence-Based Medicine, Novosibirsk State Medical University.

Novosibirsk.

K. I. Bakhareva
Research Institute of Clinical and Experimental Lymphology, Branch of the Federal Research Center Institute of Cytology and Genetics
Russian Federation

Ksenia I. Bakhareva – Junior Researcher, Laboratory of Pharmacological Modeling and Screening of Bioactive Molecules, Research Institute of Clinical and Experimental Lymphology, Branch of the Federal Research Center Institute of Cytology and Genetics.

Novosibirsk.

M. S. Soldatova
Research Institute of Clinical and Experimental Lymphology, Branch of the Federal Research Center Institute of Cytology and Genetics
Russian Federation

Marina S. Soldatova – Junior Researcher, Laboratory of Pharmacological Modeling and Screening of Bioactive Molecules, Research Institute of Clinical and Experimental Lymphology, Branch of the Federal Research Center Institute of Cytology and Genetics.

Novosibirsk.